Page last updated: 2024-10-22

alendronate and Coronary Disease

alendronate has been researched along with Coronary Disease in 6 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"We developed a decision analytic Markov model to compare the effects of alendronate therapy, raloxifene therapy, and HRT on risks of hip fracture, coronary heart disease (CHD), breast cancer, and life expectancy."3.70Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. ( Col, NF; Eckman, MH; Goldberg, RJ; Orr, RK; Pauker, SG; Ross, EM; Wong, JB, 1999)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SoRelle, R1
Vittinghoff, E1
Bauer, DC1
Gibaldi, M1
Col, NF1
Pauker, SG1
Goldberg, RJ1
Eckman, MH1
Orr, RK1
Ross, EM1
Wong, JB1
Grady, D1

Reviews

1 review available for alendronate and Coronary Disease

ArticleYear
Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy?
    Journal of clinical pharmacology, 1997, Volume: 37, Issue:12

    Topics: Alendronate; Alzheimer Disease; Calcitonin; Calcium; Coronary Disease; Diphosphonates; Endometrial N

1997

Other Studies

5 other studies available for alendronate and Coronary Disease

ArticleYear
Two markers complement each other in identifying risk.
    Circulation, 2004, Feb-24, Volume: 109, Issue:7

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Alendronate; Biomarkers; C-Reactive Protein; Calcitr

2004
Case-only analysis of treatment-covariate interactions in clinical trials.
    Biometrics, 2006, Volume: 62, Issue:3

    Topics: Alendronate; Analysis of Variance; Bias; Biometry; Clinical Trials as Topic; Cohort Studies; Coronar

2006
Contradictory hormone studies renew debate over breast cancer link.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Oct-01, Volume: 52, Issue:19

    Topics: Adult; Age Factors; Alendronate; Breast Neoplasms; Case-Control Studies; Coronary Disease; Diphospho

1995
Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.
    Archives of internal medicine, 1999, Jul-12, Volume: 159, Issue:13

    Topics: Alendronate; Bone Density; Breast Neoplasms; Coronary Disease; Decision Support Techniques; Estrogen

1999
A 60-year-old woman trying to discontinue hormone replacement therapy.
    JAMA, 2002, Apr-24, Volume: 287, Issue:16

    Topics: Alendronate; Breast Neoplasms; Contraindications; Coronary Disease; Decision Making; Estrogen Replac

2002